Logo for Contineum Therapeutics Inc

Contineum Therapeutics Investor Relations Material

Latest events

Logo for Contineum Therapeutics

Q3 2024

5 Nov, 2024
Logo for Contineum Therapeutics

Q2 2024

14 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Contineum Therapeutics Inc

Access all reports
Contineum Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel, oral small molecule therapies. The company focuses on treatments for neuroscience, inflammation, and immunology (NI&I) conditions that have significant unmet medical needs. Contineum is headquartered in San Diego, California, and its shares are listed on the NASDAQ.